Replimune Group
Develops RPx oncolytic immunotherapies for melanoma and other solid tumors.
$15.45
After-hours close−0.06 (−0.39%)
At close$15.51(−0.58%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.75 | — | — |
| Aug 2026 | −$0.69 | −$0.72 | −3.7% |
| Aug 2026 | −$0.69 | −$0.72 | −3.7% |
| Jul 2026 | −$0.73 | — | — |
| Jun 2026 | −$0.66 | −$0.76 | −14.9% |
| Jun 2026 | −$0.73 | — | — |
| Jun 2026 | −$0.73 | — | — |
| Jun 2026 | −$0.73 | — | — |
| Jun 2026 | −$0.73 | — | — |
| Jun 2026 | −$0.73 | — | — |
| Jun 2026 | −$0.73 | — | — |
| May 2026 | −$0.73 | — | — |
| May 2026 | −$0.73 | — | — |
| Feb 2026 | −$0.77 | −$0.77 | −0.2% |
The latest year is open to everyone — the 32 quarters behind it read with an account. Sign in | |||
| Nov 2025 | |||
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| Jun 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| Jun 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| Jul 2018 | |||
| Dec 2017 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 5, 2026 | −$0.75 | — | — | $1.0M | — | — |
| Aug 14, 2026 | −$0.69 | −$0.72 | −3.7% | $13.6M | — | — |
| Aug 13, 2026 | −$0.69 | −$0.72 | −3.7% | $13.6M | — | — |
| Jul 2, 2026 | −$0.73 | — | — | $5.6M | — | — |
| Jun 29, 2026 | −$0.66 | −$0.76 | −14.9% | $3.6M | — | — |
| Jun 25, 2026 | −$0.73 | — | — | $5.6M | — | — |
| Jun 18, 2026 | −$0.73 | — | — | $5.6M | — | — |
| Jun 15, 2026 | −$0.73 | — | — | $5.6M | — | — |
| Jun 11, 2026 | −$0.73 | — | — | $5.6M | — | — |
| Jun 4, 2026 | −$0.73 | — | — | $5.6M | — | — |
| Jun 1, 2026 | −$0.73 | — | — | $5.6M | — | — |
| May 29, 2026 | −$0.73 | — | — | $948.0K | — | — |
| May 28, 2026 | −$0.73 | — | — | $5.6M | — | — |
| Feb 3, 2026 | −$0.77 | −$0.77 | −0.2% | $428.6K | — | — |
The latest year is open to everyone — the 32 quarters behind it read with an account. Sign in | ||||||
| Nov 6, 2025 | ||||||
| Aug 7, 2025 | ||||||
| May 22, 2025 | ||||||
| Feb 12, 2025 | ||||||
| Nov 12, 2024 | ||||||
| Aug 8, 2024 | ||||||
| May 16, 2024 | ||||||
| Feb 8, 2024 | ||||||
| Nov 7, 2023 | ||||||
| Aug 3, 2023 | ||||||
| May 18, 2023 | ||||||
| Feb 9, 2023 | ||||||
| Nov 3, 2022 | ||||||
| Aug 4, 2022 | ||||||
| May 19, 2022 | ||||||
| Feb 3, 2022 | ||||||
| Nov 4, 2021 | ||||||
| Aug 6, 2021 | ||||||
| May 20, 2021 | ||||||
| Feb 4, 2021 | ||||||
| Nov 5, 2020 | ||||||
| Aug 7, 2020 | ||||||
| Jun 3, 2020 | ||||||
| Feb 13, 2020 | ||||||
| Nov 11, 2019 | ||||||
| Aug 14, 2019 | ||||||
| Jun 28, 2019 | ||||||
| Feb 14, 2019 | ||||||
| Nov 14, 2018 | ||||||
| Aug 30, 2018 | ||||||
| Jul 23, 2018 | ||||||
| Dec 31, 2017 | ||||||